for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

CureVac BV

CVAC.O

Latest Trade

50.03USD

Change

0.00(0.00%)

Volume

688,768

Today's Range

49.50

 - 

52.89

52 Week Range

36.15

 - 

85.00

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
50.03
Open
51.88
Volume
688,768
3M AVG Volume
--
Today's High
52.89
Today's Low
49.50
52 Week High
85.00
52 Week Low
36.15
Shares Out (MIL)
177.97
Market Cap (MIL)
8,936.17
Forward P/E
--
Dividend (Yield %)
--

Latest Developments

More

Curevac Reports Positive Preclinical Data For COVID-19 Vaccine Candidate

Curevac NV Says Initiates Phase 2A Clinical Trial Of COVID-19 Vaccine Candidate

CureVac To Receive Up To EUR 252 Euros For Further Covid-19 Vaccine Development

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About CureVac BV

CureVac AG is a Germany-based biotechnology company. The Company is engaged in the therapeutic development of messenger Ribonucleic Acid (mRNA) and RNA-based vaccines. CureVac AG focuses on developing vaccines for infectious diseases and drugs to treat cancer and rare diseases. The Company's pipeline focuses on three areas: cancer immunotherapy, prophylactic vaccines, and protein-based therapies.

Industry

Biotechnology & Drugs

Contact Info

Friedrich-Miescher-Str. 15

72076

Germany

+49.7071.98830

Key Stats

2.00 mean rating - 5 analysts
Sell
Hold
Buy
Revenue (MM, EUR)

2020(E)

0.0K
EPS (EUR)

2020(E)

-2.513
Price To Earnings (TTM)
--
Price To Sales (TTM)
433.59
Price To Book (MRQ)
--
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
--
LT Debt To Equity (MRQ)
--
Return on Investment (TTM)
--
Return on Equity (TTM)
--

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up